• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺激素释放激素对大鼠脑内多巴胺受体的调节作用

Modulation of dopamine receptors by thyrotropin-releasing hormone in the rat brain.

作者信息

Funatsu K S, Inanaga K

出版信息

Peptides. 1987 Mar-Apr;8(2):319-25. doi: 10.1016/0196-9781(87)90107-0.

DOI:10.1016/0196-9781(87)90107-0
PMID:3035515
Abstract

Nanomolar concentration of thyrotropin-releasing hormone (TRH) in vitro caused a significant reduction of [3H]apomorphine binding sites (70% of the control) in the rat striatum and the limbic forebrain. [3H]Spiperone binding was not affected by TRH. On the other hand, dopamine and apomorphine displaced [3H]TRH binding partially, suggesting the presence of a TRH receptor subpopulation that has a high affinity for dopamine agonist. Most of the neuroleptics displaced [3H]TRH binding dose-dependently in the micromolar range. (-)-Sulpiride had no affinity to TRH receptors. These findings suggest that one of the important roles of TRH as a neuromodulator is to modulate receptors for classical neurotransmitters, and this receptor-receptor interaction may be of importance in explaining the well known stimulating effects of TRH on the dopaminergic system.

摘要

体外纳摩尔浓度的促甲状腺激素释放激素(TRH)可使大鼠纹状体和边缘前脑的[3H]阿扑吗啡结合位点显著减少(降至对照的70%)。[3H]螺哌隆结合不受TRH影响。另一方面,多巴胺和阿扑吗啡可部分取代[3H]TRH结合,提示存在对多巴胺激动剂具有高亲和力的TRH受体亚群。大多数抗精神病药物在微摩尔范围内呈剂量依赖性地取代[3H]TRH结合。(-)-舒必利对TRH受体无亲和力。这些发现表明,TRH作为神经调质的重要作用之一是调节经典神经递质的受体,这种受体-受体相互作用可能在解释TRH对多巴胺能系统的众所周知的刺激作用方面具有重要意义。

相似文献

1
Modulation of dopamine receptors by thyrotropin-releasing hormone in the rat brain.促甲状腺激素释放激素对大鼠脑内多巴胺受体的调节作用
Peptides. 1987 Mar-Apr;8(2):319-25. doi: 10.1016/0196-9781(87)90107-0.
2
5-Hydroxytryptamine and (+)-lysergic acid diethylamide displace [3H]thyrotropin-releasing hormone at its binding sites in the rat limbic forebrain.5-羟色胺和(+)-麦角酸二乙酰胺在大鼠边缘前脑的结合位点取代[3H]促甲状腺激素释放激素。
Regul Pept. 1986 Jul;14(4):293-9. doi: 10.1016/0167-0115(86)90171-0.
3
Dopaminergic receptors in bovine retina and their interaction with thyrotropin-releasing hormone.牛视网膜中的多巴胺能受体及其与促甲状腺激素释放激素的相互作用。
J Neurochem. 1983 Dec;41(6):1587-95. doi: 10.1111/j.1471-4159.1983.tb00868.x.
4
A novel substance P binding site in rat brain regions modulates TRH receptor binding.大鼠脑区中一种新型的P物质结合位点调节促甲状腺激素释放激素受体结合。
Neurochem Res. 1990 Oct;15(10):1045-9. doi: 10.1007/BF00965752.
5
Norvaline2-TRH: binding to TRH receptors in rat brain homogenates.正缬氨酸 - 2 - 促甲状腺激素释放激素:与大鼠脑匀浆中的促甲状腺激素释放激素受体结合。
Eur J Pharmacol. 1990 May 3;180(1):1-12. doi: 10.1016/0014-2999(90)90586-u.
6
Influence of thyrotropin-releasing hormone on general behavior and striatal [3H]spiperone binding in developing rats.促甲状腺激素释放激素对发育中大鼠一般行为及纹状体[3H]司哌罗宁结合的影响。
J Pharmacobiodyn. 1983 Sep;6(9):607-12. doi: 10.1248/bpb1978.6.607.
7
Intraventricular administration of thyrotrophin-releasing hormone (TRH) suppresses prolactin secretion and synthesis: a possible involvement of dopamine release by TRH from rat hypothalamus.脑室内注射促甲状腺激素释放激素(TRH)可抑制催乳素的分泌和合成:TRH从大鼠下丘脑释放多巴胺可能参与其中。
J Endocrinol. 1992 Apr;133(1):59-66. doi: 10.1677/joe.0.1330059.
8
Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.阿片类物质作用于促甲状腺激素释放激素脑受体的证据。
Brain Res. 1986 Mar 19;368(2):262-7. doi: 10.1016/0006-8993(86)90570-6.
9
Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
Neuropharmacology. 1987 Aug;26(8):1141-6. doi: 10.1016/0028-3908(87)90260-7.
10
Central and peripheral type benzodiazepine ligands displace [3H][3-ME-HIS2]TRH from its binding sites in the brain and the anterior pituitary and antagonize the effect of TRH in the rat duodenum.中枢型和外周型苯二氮䓬配体可将[3H][3-甲基组氨酸2]促甲状腺激素释放激素从其在脑和垂体前叶的结合位点上置换下来,并拮抗促甲状腺激素释放激素在大鼠十二指肠中的作用。
Neuropeptides. 1991 Jul;19(3):147-55. doi: 10.1016/0143-4179(91)90112-v.

引用本文的文献

1
Widening spectrum of neuroleptic malignant syndrome: Case series.抗精神病药物恶性综合征的谱系扩大:病例系列
J Anaesthesiol Clin Pharmacol. 2022 Apr-Jun;38(2):309-314. doi: 10.4103/joacp.JOACP_8_21. Epub 2021 Oct 11.
2
Neuroleptic malignant syndrome with thyroid disorder: An unusual case report.伴有甲状腺疾病的抗精神病药恶性综合征:一例罕见病例报告。
Medicine (Baltimore). 2017 Sep;96(39):e8191. doi: 10.1097/MD.0000000000008191.
3
Neuroleptic malignant syndrome and hypothyroidism.抗精神病药恶性综合征与甲状腺功能减退症
J Neurol Neurosurg Psychiatry. 1990 Jun;53(6):517-8. doi: 10.1136/jnnp.53.6.517.